Health and Fitness Health and Fitness
Fri, August 24, 2012
Thu, August 23, 2012
[ Thu, Aug 23rd 2012 ] - Market Wire
General Growth Properties, Inc.

Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference


Published on 2012-08-23 12:31:23 - Market Wire
  Print publication without navigation


Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference -- ATLANTA, Aug. 23, 2012 /PRNewswire/ --

Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference

[ ]

ATLANTA, Aug. 23, 2012 /PRNewswire/ -- Alimera Sciences, Inc. (Nasdaq: [ ALIM ]) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Rick Eiswirth, Chief Operating Officer and Chief Financial Officer, will present at the Stifel Nicolaus Healthcare Conference at 3:15 P.M. ET on Thursday, September 6, 2012 in Boston, MA.

The presentation will be webcast live and can be accessed on the Investor Relations section of the corporate website at [ http://www.alimerasciences.com ]. For those who are not available to listen to the live broadcast, the webcast will be archived for 30 days.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently Alimera is focused on diseases affecting the back of the eye, or retina. Its primary product, ILUVIEN, is an intravitreal implant containing fluocinolone acetonide (FAc), a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease.

ICR, LLC

for Alimera Sciences

John Mills

310-954-1105

[ John.Mills@icrinc.com ]


SOURCE Alimera Sciences, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.alimerasciences.com ]